Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein
Phase 4
Suspended
- Conditions
- Fluorescein Angiography
- Interventions
- First Posted Date
- 2017-08-10
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- Kresge Eye Institute
- Target Recruit Count
- 79
- Registration Number
- NCT03244982
- Locations
- 🇺🇸
Kresge Eye Institute, Detroit, Michigan, United States
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2012-09-27
- Lead Sponsor
- Kresge Eye Institute
- Registration Number
- NCT00618644
- Locations
- 🇺🇸
Kresge Eye Institute, Detroit, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath